pH响应性聚膦腈水凝胶的制备与表征

以N,N-二甲基乙二胺为阳离子型取代基, 甲基丙烯酸羟乙酯或烯丙胺为共取代基, 制备了同时带有pH响应性侧基和不饱和双键侧基的聚膦腈. 该聚合物的结构和组成经¹H NMR和FTIR确认后, 通过自由基引发交联得到聚膦腈凝胶. 凝胶在不同介质中的吸水率测试结果表明, 该阳离子型聚膦腈水凝胶的溶胀行为受聚合物侧基组成、介质pH、离子强度和阴离子价态影响显著, 有望与葡萄糖氧化酶结合后实现对胰岛素的葡萄糖响应释放.     

葡萄糖基聚膦腈水凝胶的制备

通过对葡萄糖的羟基引入保护基再与聚二氯磷腈反应后用强酸脱保护制得侧链含部分葡萄糖基的聚膦腈,然后测量聚合物与植物外源凝集素ConA混合溶液的透光率的变化来研究凝胶化过程.结果表明,在ConA的浓度相同的情况下,聚合物溶液的浓度越大,越容易形成凝胶;第二取代基团的水溶性好,葡萄糖的侧基比例大,有益于凝胶的形成.     

静电喷雾法制备聚膦腈微球

用静电喷雾法制备了粒径窄分布的甘氨酸乙酯-苯丙氨酸乙酯取代聚膦腈的微球.主要探讨了溶剂、溶液浓度、流速、喷射电压及接收距离对微球形貌和粒径的影响.微球的表面形貌与溶剂性质和聚合物溶液浓度密切相关,微球粒径受聚合物溶液流速的影响比较显著,随流速增大粒径呈单调上升趋势.结果显示对于[η]=0.1 dL/g的(甘氨酸乙酯)0.3(苯丙氨酸乙酯)0.7取代聚膦腈,以0.25 g/mL的四氢呋喃溶液进行静电喷雾,可获得粒径分布窄(1~2μm)且近球形的微粒,其工艺条件可进一步用于载药聚膦腈微球的制备和控制释放研究.     

直链淀粉交联氨基酸酯取代聚膦腈杂化材料的制备

利用直链淀粉与甘/丙氨酸乙酯共取代聚膦腈交联, 制得了一种具有网络结构的新型杂化材料. 实验结果表明, 淀粉衍生物上的羟基转变为醇钠后, 可与聚膦腈分子链上的P-Cl键发生亲核取代反应; 所得聚合物膜无明显相分离, 力学性能优于具有相似组成的直链淀粉/聚膦腈共混膜, 表面亲水性和吸水率与对应的共混膜接近, 且均高于纯聚膦腈膜. 因此, 该聚合物可作为杂化生物材料用于药物控制释放和组织工程方面的研究.     

聚膦腈在药物控释系统中的应用

聚膦腈由于其具有良好的生物相容性，可生物降解性及易于功能化的特性而成为一类独特的药物控释材料。本文就疏水性线型聚膦腈，聚膦腈水凝胶及聚膦腈高分子药物在药物控释系统中的应用作一简要综述。     

聚苯氧基膦腈的合成及其电纺纤维的制备

以环状三聚六氯磷腈(HCCP)为原料,采用热开环聚合方法,合成了聚二氯磷腈,再利用亲核取代反应合成了聚苯氧基膦腈(PPPh).采用FT-IR、1H NMR、GPC、DSC、TGA等对所得到的聚合物进行了结构表征和性能测试.通过静电纺丝法制备聚苯氧基膦腈纤维,研究了纺丝液浓度、电场强度、挤出速度等对纤维形态的影响.结果表明,在聚合物溶液浓度为7(wt)%～8(wt)%、挤出速度为0.3～1.0 mL/h、接收距离为20cm、电压为22kV的静电纺丝条件下,可制备纤维直径为300～800 nm的PPPh纤维.     

聚[(甲氧基乙氧基乙氧基)1.0(乙氧基吡咯烷酮)1.0]膦腈的合成及性能研究

用三氯化铝催化六氯三聚膦腈开环聚合制得线性聚二氯膦腈(PDCP), 通过PDCP磷原子上的亲核取代反应, 合成了新的水溶性高分子聚[(甲氧基乙氧基乙氧基)_1.0(乙氧基吡咯烷酮)_1.0]膦腈(P3), 用³¹P NMR, ¹H NMR, ¹³C NMR和IR对其结构进行了确证, 用DSC测定了其玻璃化转变温度T_g和熔融温度T_m, 用蒸汽压渗透法(VPO)测定了其数均分子量. 改进了聚二(乙氧基吡咯烷酮)膦腈(P2)的合成方法. 体外降解实验表明, P3具有和P2类似的pH响应性降解行为, 降解速率在pH=5.0时最快, 而在pH=7.4和8.0时较慢. P3在所测试的3个pH缓冲溶液中均比P2降解慢. 用³¹P NMR、薄层色谱(TLC)和滴定法对降解产物进行了检测, 初步推断了P3在不同pH介质中的水解机理, 其在pH=5.0的缓冲溶液中的降解, 除侧链断裂外, 聚膦腈的骨架也裂解; 而在pH=7.4和8.0时的降解仅为侧链的断裂. 用噻唑蓝(MTT)比色法进行的体外细胞毒性评价实验表明, P3及其在pH=5.0的缓冲溶液中降解49 d后的产物均对细胞表现出了很好的生物相容性, 而且其降解产物在浓度为800 μg/mL时还表现出一定的促进细胞增殖作用.     

含有锂皂土/聚多巴胺复合纳米微粒的再生丝蛋白水凝胶

在辣根过氧化物酶/过氧化氢酶促交联(化学交联)制备再生丝蛋白化学交联凝胶的过程中,通过引入锂皂土/聚多巴胺复合纳米材料作为第二组分,以调节反应并提高化学交联效率;再经乙醇熟化后,再生丝蛋白化学交联凝胶中可进一步形成物理网络,进而得到双交联凝胶.结果表明,第二组分的引入不仅能够提高再生丝蛋白化学交联水凝胶的力学性能,并有利于后续均匀物理交联网络的形成,致使最终所得双交联水凝胶具有更好的力学性能.同时,由此制备的双交联水凝胶传承了再生丝蛋白良好的生物相容性以及与交联结构密切相关的生物降解性,并具备了诱导干细胞成骨分化的能力,因而在软骨修复等领域具有潜在的应用价值.     

基于含苯硼酸三嵌段共聚物的糖响应性水凝胶

设计合成了一类新型结构的聚环氧乙烷(PEO)大分子链转移剂,调控3-丙烯酰胺基苯硼酸(AAPBA)的可逆加成断裂-链转移(RAFT)自由基聚合,合成得到3种PAAPBA链段长度不同的PAAPBA-bPEO-b-PAABPA3嵌段共聚物.研究了3种聚合物在生理pH值下的凝胶化行为,证明凝胶的形成与PAABPA的长度有关,当该链段较长时,由于PAABPA链段疏水性太强,不能形成稳定的水凝胶.详细研究了聚合物浓度、温度、葡萄糖浓度对凝胶流变行为的影响,证明共聚物浓度越高,形成的凝胶的强度更大,性质上更接近于固体,浓度较高条件下形成的凝胶的转变温度较高.凝胶表现出葡萄糖敏感性,当高葡萄糖存在时,随时间延长,凝胶会发生崩解直至最后溶解.凝胶亲水微区能包载蛋白质FITC-BSA,加入葡萄糖后,FITC-BSA的释放加快.     

葡萄糖敏感型水凝胶最新研究进展

糖尿病是由于胰岛素分泌不足引起的一种新陈代谢疾病,对糖尿病的有效控制在于不间断的测定血糖浓度并适时的释放胰岛素.因此,能够对环境葡萄糖浓度变化做出应答的功能型高分子材料葡萄糖敏感水凝胶,在生物化学和生物医学领域引起了极大的关注.本文综述了近几年国内外葡萄糖敏感型水凝胶的研究现状,重点介绍了应用于胰岛素释放体系和生物传感器领域的载有葡萄糖氧化酶、伴刀豆球蛋白和苯硼酸基团等葡萄糖敏感型水凝胶的作用机理和最新研究进展,展望了今后的研究方向.     

A biomimetic sensor based on specific receptor ETBD and Fe3O4@Au/MoS2/GN for signal enhancement shows highly selective electrochemical response to ultra-trace lead (II)

Journal of Solid State Electrochemistry - A lead-chelating ligand, 2,2′-((1E)-((4-((2-mercaptoethyl)thio)-1,2phenylene)bis(azany-lylidene))bis(methanylylide-ne))diphenol (ETBD), was...     

Synthesis and in-vitro antioxidant activities of some coumarin derivatives containing 1,2,3-triazole ring

A new green protocol was developed for the S-alkylation of 2-mercapto-1,3,4-oxadiazole by the reaction of 5-substituted-2-mercapto-1,3,4-oxadiazole with propargyl bromide in sodium bicarbonate in water. The newly synthesized 5-[(substitutedphenoxy)methyl]-2-[(prop-2-yn-1-yl)sulfanyl]-1,3,4-oxadiazole when reacted with azidomethyl coumarins underwent regioselective reaction yielding 4-(((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethyl)-1H-1,2,3-triazol-1-yl)methyl)-6-methyl)-2H-chromene-2-one or 1-((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethy)-1H-1,2,3-triazol-1-yl-)methyl)-3H-benzo[f]chromene-3-one. Structures of the newly synthesized compounds were confirmed by spectral and analytical data. The compounds were screened for their in-vitro antioxidant property.     

指示稳定性的反相超高效液相色谱评价原料药和制剂配方中奈必洛尔杂质的方法建立与验证(英文)

A sensitive,stability-indicating gradient reverse phase ultra performance liquid chromatographic method has been developed for the quantitative estimation of nebivolol impurities in active pharmaceutical ingredient(API)and pharmaceutical formulation.Efficient chromatographic separation was achieved on an Acquity BEH C18 column(100 mm×2.1 mm,1.7μm)with mobile phase of a gradient mixture.The flow rate of the mobile phase was 0.18 mL/min with column temperature of 30℃and detection wavelength of 281 nm.The relative response factor values of(R*)-2-(benzylamino)-1-((S*)-6-fluorochroman-2-yl)ethanol((R*S*)NBV-1),(R)-1-((R)-6-fluorochroman-2-yl)-2-((S)-2-((S)-6-fluoro-chroman-2-yl)-2-hydroxyethylamino)ethanol((RRSS)NBV-3),1-(chroman-2-yl)-2-(2-(6-fluorochroman-2-yl)-2-hydroxy ethyl amino)ethanol(monodesfluoro impurity),(S)-1-((R)-6-fluorochroman-2-yl)-2-((R)-2((S)-6-fluoro-chroman-2-yl)-2-hydroxyethylamino)ethanol hydrochloride((RSRS)NBV-3)and(R*)-1-((S*)-6-fluorochroman-2-yl)-2-((S*)-2-((S*)-6-fluoro-chroman-2-yl)-2-hydroxyethylamino)ethanol((R*S*S*S*)NBV-2)were 0.65,0.91,0.68,0.92 and 0.91 respectively.Nebivolol formulation sample was subjected to the stress conditions of acid,base,oxidative,hydrolytic,thermal,humidity and photolytic degradation.Nebivolol was found to degrade significantly under peroxide stress condition.The degradation products were well resolved from nebivolol and its impurities.The peak purity test results confirmed that the nebivolol peak was homogenous and pure in all stress samples and the mass balance was found to be more than 98%,thus proving the stability-indicating power of the method.The developed method was validated according to International Conference on Hormonization(ICH)guidelines with respect to specificity,linearity,limits of detection and quantification,accuracy,precision and robustness.     

Synthesis and reactivity of an isolable cobalt(I) complex containing a β-diketiminate-based acyclic tetradentate ligand

A model for cobalamin was synthesized using a new monoanionic tetradentate nitrogen donor ligand; 2-(4-tolyl)-1,3-bis(2-isopropylpyridyl)propenediimine (Tol-BDI((2-pp)2)H) (1), which utilizes isopropylpyridines as pendant arms on a β-diketiminate (BDI) backbone. During the synthesis of 1, the rearrangement product, Tol-BDI((2-pp)(4-pp))H (2) was observed. Metalation of 1 with zinc iodide and cobalt chloride yielded the corresponding Tol-BDI((2-pp)2)ZnI (3) and Tol-BDI((2-pp)2)CoCl (4) complexes. The redox properties of 4 in comparison to cobalamin were examined through electrochemical studies. Electrochemical and bulk reduction of complex 4 gave a diamagnetic cobalt(I) complex, Tol-BDI((2-pp)2)Co (5). Reactivity of 5 toward C-X bonds was investigated using methyl iodide and 1-iodo-2-(trimethylsilyl)acetylene, yielding Tol-BDI((2-pp)2)Co(CH(3))I and Tol-BDI((2-pp)2)Co(C(2)Si(CH(3))(3))I respectively. Synthesis and characterization details for these complexes, including the crystal structure of 3, are reported.     

Two- and three-body photodissociation dynamics of diiodobromide (I2Br-) anion

The photodissociation of gas-phase I(2)Br(-) was investigated using fast beam photofragment translational spectroscopy. Anions were photodissociated from 300 to 270 nm (4.13-4.59 eV) and the recoiling photofragments were detected in coincidence by a time- and position-sensitive detector. Both two- and three-body channels were observed throughout the energy range probed. Analysis of the two-body dissociation showed evidence for four distinct channels: Br(-) + I(2), I(-) + IBr, Br+I(2) (-), and I + IBr(-). In three-body dissociation, Br((2)P(3∕2)) + I((2)P(3∕2)) + I(-) and Br(-) + I((2)P(3∕2)) + I((2)P(3∕2)) were produced primarily from a concerted decay mechanism. A sequential decay mechanism was also observed and attributed to Br(-)((1)S)+I(2)(B(3)Π(0u) (+)) followed by predissociation of I(2)(B).     

Preliminary studies on a novel synthesis of β-amino acids: stereocontrolled transformation of d- and l-glyceraldehyde into 3-amino-2-(2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoic acids

A stereocontrolled synthesis of the methyl ester of (2S)-3-amino-2-((4′S)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoic acid from d-glyceraldehyde is described for the first time. This method involves the stereoselective Michael addition of the lithium salt of tris(phenylthio)methane to (S)-2,2-dimethyl-4-((E)-2-nitrovinyl)-1,3-dioxolane followed by hydrolysis of the resulting (4S)-2,2-dimethyl-4-((2′S)-3′-nitro-1′,1′,1′-tris(phenylthio)propan-2′-yl)-1,3-dioxolane to (2S)-methyl 2-((4′S)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)-3-nitropropanoate, which was finally reduced to the target compound. A similarly stereocontrolled transformation of l-glyceraldehyde into (2R)-methyl 3-amino-2-((4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoate is also described.     

Photodissociation channels for N2O near 130 nm studied by product imaging

The photodissociation of N(2)O at wavelengths near 130 nm has been investigated by velocity-mapped product imaging. In all, five dissociation channels have been detected, leading to the following products: O((1)S)+N(2)(X (1)Sigma), N((2)D)+NO(X (2)Pi), N((2)P)+NO(X (2)Pi), O((3)P) + N(2)(A (3)Sigma(+) (u)), and O((3)P) + N(2)(B (3)Pi(g)). The most significant channel is to the products O((1)S) + N(2)(X(1)Sigma), with strong vibrational excitation in the N(2). The O((3)P) + N(2)(A,B):N((2)D,(2)P) + NO branching ratio is measured to be 1.4 +/- 0.5, while the N(2)(A) + O((3)P(J)):N(2)(B) + O((3)P(J)) branching ratio is determined to be 0.84+/-0.09. The spin-orbit distributions for the O((3)P(J)), N((2)P(J)), and N((2)D(J)) products were also determined. The angular distributions of the products are in qualitative agreement with excitation to the N(2)O(D (1)Sigma(+)) state, with participation as well by the (3)Pi(v) state.     

含喹唑啉硫醚的杨梅素衍生物的设计、合成及生物活性研究

以杨梅苷为原料,通过活性拼接,设计并合成一系列含喹唑啉硫醚的杨梅素衍生物,其结构通过1H NMR、13C NMR、19F NMR和HRMS进行确证.生物活性测试结果表明,该类化合物对水稻白叶枯病菌(X.Oryzae)、柑橘溃疡病菌(X. Citri)和烟草青枯病菌(R. Solanacearum)表现出一定的抑制活性.其中, 5,7-二甲氧基-3-(3-((6-溴喹唑啉-4-基)硫基)丙氧基)-2-(3,4,5-三甲氧基苯基)-4H-色烯-4-酮(A15)对水稻白叶枯病菌的EC50值为13.9μg/mL,优于对照药叶枯唑(88.9μg/mL)和噻菌铜(68.1μg/mL);5,7-二甲氧基-3-(4-((6-氯喹唑啉-4-基)硫基)丁氧基)-2-(3,4,5-三甲氧基苯基)-4H-色烯-4-酮(A3)、5,7-二甲氧基-3-(3-((6-氯喹唑啉-4-基)硫基)丙氧基)-2-(3,4,5-三甲氧基苯基)-4H-色烯-4-酮(A14)、5,7-二甲氧基-3-(3-((6-溴喹唑啉-4-基)硫基)丙氧基)-2-(3,4,5-三甲氧基苯基)-4H-色烯-4-酮(A15)和5,7-二甲氧基-3-(3-((6-氟喹唑啉-4-基)硫基)丙氧基)-2-(3,4,5-三甲氧基苯基)-4H-色烯-4-酮(A16)对烟草青枯病菌的EC50值分别为1.1,14.0,11.9和7.5μg/mL,优于对照药叶枯唑(38.5μg/mL)和噻菌铜(184.8μg/mL).活体实验结果表明,化合物A15对水稻白叶枯病菌的具有良好治疗活性和保护活性.通过扫描电镜成像初步探讨了目标化合物A3对烟草青枯病菌和A15对水稻白叶枯病菌的抑菌作用机制.     

Chelate ring size variations and their effects on coordination chemistry and catechol dioxygenase reactivity of iron(III) complexes

The catechol dioxygenase reactivity of iron(III) complexes using tripodal ligands was investigated. Increasing, as well as decreasing, chelate ring sizes in the highly active complex [Fe(tmpa)(dbc)]B(C6H5)4 (tmpa = tris[(2-pyridyl)methyl]amine; dbc = 3,5-di-tert-butylcatecholate dianion), using related ligands, only resulted in decreased reactivity of the investigated compounds. A detailed low-temperature stopped-flow investigation of the reaction of dioxygen with [Fe(tmpa)(dbc)]B(C6H5)4 was performed, and activation parameters of DeltaH++ = 23 +/- 1 kJ mol(-1) and DeltaS++ = -199 +/- 4 J mol(-1) K(-1) were obtained. Crystal structures of bromo-(tetrachlorocatecholato-O,O')(bis((2-pyridyl)methyl)-2-pyridylamine-N,N',N')-iron(III), (mu-oxo)-bis(bromo)(bis((2-pyridyl)methyl)-2-pyridylamine-N,N',N' ',N')-diiron(III), dichloro-((2-(2-pyridyl)ethyl)bis((2-pyridyl)methyl)amine-N,N',N' ',N')-iron(III) and (tetrachlorocatecholato-O,O')((2-(2-pyridyl)ethyl)bis((2-pyridyl)methyl)amine-N,N',N' ',N')-iron(III) are reported.